The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/36287
StudyName: Eligibility Lung, Carcinoma NCT02066038
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 29.04.2019
License: Creative Commons BY 4.0

----

Description: 
Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation; ODM derived from: https://clinicaltrials.gov/show/NCT02066038
